Spatiotemporal evolution of AML immune microenvironment remodeling and RNF149-driven drug resistance through single-cell multidimensional analysis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Spatiotemporal evolution of AML immune microenvironment remodeling and RNF149-driven drug resistance through single-cell multidimensional analysis ; volume:21 ; number:1 ; day:27 ; month:10 ; year:2023 ; pages:1-21 ; date:12.2023
Journal of translational medicine ; 21, Heft 1 (27.10.2023), 1-21, 12.2023
- Urheber
-
Wu, Xin
Wu, Zhongguang
Deng, Woding
Xu, Rong
Ban, Chunmei
Sun, Xiaoying
Zhao, Qiangqiang
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12967-023-04579-5
- URN
-
urn:nbn:de:101:1-2024011514292635777110
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
07.08.2025, 11:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wu, Xin
- Wu, Zhongguang
- Deng, Woding
- Xu, Rong
- Ban, Chunmei
- Sun, Xiaoying
- Zhao, Qiangqiang
- SpringerLink (Online service)
Ähnliche Objekte (12)
Exponential stability of traveling waves for a nonlocal dispersal SIR model with delay
Data-driven multiple-level analysis of gut-microbiome-immune-joint interactions in rheumatoid arthritis
Large-scale mining disease comorbidity relationships from post-market drug adverse events surveillance data
Towards understanding brain-gut-microbiome connections in Alzheimer’s disease
A genomics-based systems approach towards drug repositioning for rheumatoid arthritis
Context-sensitive network analysis identifies food metabolites associated with Alzheimer’s disease: an exploratory study
Large-scale extraction of accurate drug-disease treatment pairs from biomedical literature for drug repurposing
Mining comorbidities of opioid use disorder from FDA adverse event reporting system and patient electronic health records
Large-scale combining signals from both biomedical literature and the FDA Adverse Event Reporting System (FAERS) to improve post-marketing drug safety signal detection
Phenome-based gene discovery provides information about Parkinson’s disease drug targets
The horizontal-to-vertical spectral ratio and its applications
Andersson lesion in ankylosing spondylitis
Exponential stability of traveling waves for a nonlocal dispersal SIR model with delay
Data-driven multiple-level analysis of gut-microbiome-immune-joint interactions in rheumatoid arthritis
Large-scale mining disease comorbidity relationships from post-market drug adverse events surveillance data
Towards understanding brain-gut-microbiome connections in Alzheimer’s disease
A genomics-based systems approach towards drug repositioning for rheumatoid arthritis
Context-sensitive network analysis identifies food metabolites associated with Alzheimer’s disease: an exploratory study
Large-scale extraction of accurate drug-disease treatment pairs from biomedical literature for drug repurposing
Mining comorbidities of opioid use disorder from FDA adverse event reporting system and patient electronic health records
Large-scale combining signals from both biomedical literature and the FDA Adverse Event Reporting System (FAERS) to improve post-marketing drug safety signal detection
Phenome-based gene discovery provides information about Parkinson’s disease drug targets
The horizontal-to-vertical spectral ratio and its applications
Andersson lesion in ankylosing spondylitis
Exponential stability of traveling waves for a nonlocal dispersal SIR model with delay
Data-driven multiple-level analysis of gut-microbiome-immune-joint interactions in rheumatoid arthritis
Large-scale mining disease comorbidity relationships from post-market drug adverse events surveillance data
Towards understanding brain-gut-microbiome connections in Alzheimer’s disease
A genomics-based systems approach towards drug repositioning for rheumatoid arthritis
Context-sensitive network analysis identifies food metabolites associated with Alzheimer’s disease: an exploratory study
Large-scale extraction of accurate drug-disease treatment pairs from biomedical literature for drug repurposing
Mining comorbidities of opioid use disorder from FDA adverse event reporting system and patient electronic health records
Large-scale combining signals from both biomedical literature and the FDA Adverse Event Reporting System (FAERS) to improve post-marketing drug safety signal detection
Phenome-based gene discovery provides information about Parkinson’s disease drug targets
The horizontal-to-vertical spectral ratio and its applications